Entera Bio ENTX
NASDAQ ENTX
$2.69 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Gross Margin (2019 - 2024)

Updated

Entera Bio (ENTX) posted Gross Margin of 4.97% for FY2024.

Analysis

Entera Bio (ENTX) Gross Margin (2019 - 2024) Analysis & Trends

Since FY2020, Entera Bio has reported Gross Margin for 4 years.

  • Annual Gross Margin shows a four-year change of -12.84 percentage points (FY2020 to FY2024).
  • Business Quant data shows ENTX's Gross Margin at 24.63% in FY2022 (-10.05 pp), 34.68% in FY2021 (+16.87 pp) and 17.81% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Entera Bio 132.59 Mn 101.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 15.79%
Dec 31, 2022 42.86%
Sep 30, 2022 25.00%
Jun 30, 2022 25.00%
Mar 31, 2022 20.59%
Dec 31, 2021 17.58%
Sep 30, 2021 53.57%
Jun 30, 2021 9.17%
Mar 31, 2021 53.50%
Jun 30, 2020 40.38%
Jun 30, 2019 16.22%
API Access

Entera Bio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ENTX&period=max&api_key=YOUR_API_KEY